These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 12738716

  • 21. Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma.
    Advani R, Forero-Torres A, Furman RR, Rosenblatt JD, Younes A, Ren H, Harrop K, Whiting N, Drachman JG.
    J Clin Oncol; 2009 Sep 10; 27(26):4371-7. PubMed ID: 19636010
    [Abstract] [Full Text] [Related]

  • 22. Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.
    Rizvi NA, Riely GJ, Azzoli CG, Miller VA, Ng KK, Fiore J, Chia G, Brower M, Heelan R, Hawkins MJ, Kris MG.
    J Clin Oncol; 2008 Feb 01; 26(4):639-43. PubMed ID: 18235124
    [Abstract] [Full Text] [Related]

  • 23. Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial.
    Harrop R, Connolly N, Redchenko I, Valle J, Saunders M, Ryan MG, Myers KA, Drury N, Kingsman SM, Hawkins RE, Carroll MW.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3416-24. PubMed ID: 16740766
    [Abstract] [Full Text] [Related]

  • 24. Phase I radioimmunotherapy trial with iodine-131--labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer.
    Hajjar G, Sharkey RM, Burton J, Zhang CH, Yeldell D, Matthies A, Alavi A, Losman MJ, Brenner A, Goldenberg DM.
    Clin Colorectal Cancer; 2002 May 01; 2(1):31-42. PubMed ID: 12453334
    [Abstract] [Full Text] [Related]

  • 25. Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer.
    Eisen T, Thatcher N, Leyvraz S, Miller WH, Couture F, Lorigan P, Lüthi F, Small D, Tanovic A, O'Brien M.
    Lung Cancer; 2009 Apr 01; 64(1):60-5. PubMed ID: 18692272
    [Abstract] [Full Text] [Related]

  • 26. Phase I study of N(1),N(11)-diethylnorspermine in patients with non-small cell lung cancer.
    Hahm HA, Ettinger DS, Bowling K, Hoker B, Chen TL, Zabelina Y, Casero RA.
    Clin Cancer Res; 2002 Mar 01; 8(3):684-90. PubMed ID: 11895896
    [Abstract] [Full Text] [Related]

  • 27. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
    Wong JY, Chu DZ, Williams LE, Yamauchi DM, Ikle DN, Kwok CS, Liu A, Wilczynski S, Colcher D, Yazaki PJ, Shively JE, Wu AM, Raubitschek AA.
    Clin Cancer Res; 2004 Aug 01; 10(15):5014-21. PubMed ID: 15297402
    [Abstract] [Full Text] [Related]

  • 28. Preliminary report of a phase I study of combination chemotherapy and humanized A33 antibody immunotherapy in patients with advanced colorectal cancer.
    Welt S, Ritter G, Williams C, Cohen LS, Jungbluth A, Richards EA, Old LJ, Kemeny NE.
    Clin Cancer Res; 2003 Apr 01; 9(4):1347-53. PubMed ID: 12684403
    [Abstract] [Full Text] [Related]

  • 29. Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR.
    Juweid ME, Hajjar G, Stein R, Sharkey RM, Herskovic T, Swayne LC, Suleiman S, Pereira M, Rubin AD, Goldenberg DM.
    J Nucl Med; 2000 Jan 01; 41(1):93-103. PubMed ID: 10647610
    [Abstract] [Full Text] [Related]

  • 30. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
    Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Salgia R, Posther KE, Nguyen B, Haraf DJ, Vokes EE.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):515-22. PubMed ID: 17255273
    [Abstract] [Full Text] [Related]

  • 31. Clinical implications of fibroblast activation protein in patients with colon cancer.
    Henry LR, Lee HO, Lee JS, Klein-Szanto A, Watts P, Ross EA, Chen WT, Cheng JD.
    Clin Cancer Res; 2007 Mar 15; 13(6):1736-41. PubMed ID: 17363526
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A phase 1 study of mapatumumab (fully human monoclonal antibody to TRAIL-R1) in patients with advanced solid malignancies.
    Hotte SJ, Hirte HW, Chen EX, Siu LL, Le LH, Corey A, Iacobucci A, MacLean M, Lo L, Fox NL, Oza AM.
    Clin Cancer Res; 2008 Jun 01; 14(11):3450-5. PubMed ID: 18519776
    [Abstract] [Full Text] [Related]

  • 35. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
    Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K, Yamaguchi K, Yamada Y, Hanada S, Tamura K, Nakamura S, Inagaki H, Ohshima K, Kiyoi H, Ishida T, Matsushima K, Akinaga S, Ogura M, Tomonaga M, Ueda R.
    J Clin Oncol; 2010 Mar 20; 28(9):1591-8. PubMed ID: 20177026
    [Abstract] [Full Text] [Related]

  • 36. A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer.
    Ishikawa A, Motohashi S, Ishikawa E, Fuchida H, Higashino K, Otsuji M, Iizasa T, Nakayama T, Taniguchi M, Fujisawa T.
    Clin Cancer Res; 2005 Mar 01; 11(5):1910-7. PubMed ID: 15756017
    [Abstract] [Full Text] [Related]

  • 37. Phase I clinical trial of the chimeric monoclonal antibody (c30.6) in patients with metastatic colorectal cancer.
    Ward RL, Packham D, Smythe AM, Murray J, Anderson-Stewart P, Kitchen N, Muirhead R, Phillips P, Gray P, Bigg-Wither G, Prabakaran K, Freund J, Fullham M, Rule M, Dalley D, Meagher A, Hawkins NJ, Smith GM.
    Clin Cancer Res; 2000 Dec 01; 6(12):4674-83. PubMed ID: 11156219
    [Abstract] [Full Text] [Related]

  • 38. Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study.
    Nishimoto N, Yoshizaki K, Maeda K, Kuritani T, Deguchi H, Sato B, Imai N, Suemura M, Kakehi T, Takagi N, Kishimoto T.
    J Rheumatol; 2003 Jul 01; 30(7):1426-35. PubMed ID: 12858437
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.